Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuen Yee Cheng

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Molecular Cancer|June 2, 2016
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaYuen Yee Cheng, Casey M Wright, Michaela B Kirschner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural MesotheliomaSteven C Kao, Yuen Yee Cheng, Marissa Williams, et al.
Plos One|August 30, 2018
BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic stateEmma M Rath, Yuen Yee Cheng, Mark Pinese, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2025
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesotheliomaHuaikai Shi, Ta-Kun Yu, Ben Johnson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 8, 2022
Controlled dual release of dihydrotestosterone and flutamide from polycaprolactone electrospun scaffolds accelerate burn wound healingHuaikai Shi, Kevin H-Y Tsai, Duncan Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesotheliomaMichaela B Kirschner, Yuen Yee Cheng, Bahareh Badrian, et al.
Oncotarget|July 1, 2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaMarissa Williams, Michaela B Kirschner, Yuen Yee Cheng, et al.
British Journal of Cancer|August 12, 2015
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisMichaela B Kirschner, Emily Pulford, Mir Alireza Hoda, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Molecular Cancer|June 2, 2016
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaYuen Yee Cheng, Casey M Wright, Michaela B Kirschner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural MesotheliomaSteven C Kao, Yuen Yee Cheng, Marissa Williams, et al.
Plos One|August 30, 2018
BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic stateEmma M Rath, Yuen Yee Cheng, Mark Pinese, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2025
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesotheliomaHuaikai Shi, Ta-Kun Yu, Ben Johnson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 8, 2022
Controlled dual release of dihydrotestosterone and flutamide from polycaprolactone electrospun scaffolds accelerate burn wound healingHuaikai Shi, Kevin H-Y Tsai, Duncan Ma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesotheliomaMichaela B Kirschner, Yuen Yee Cheng, Bahareh Badrian, et al.
Oncotarget|July 1, 2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaMarissa Williams, Michaela B Kirschner, Yuen Yee Cheng, et al.
British Journal of Cancer|August 12, 2015
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisMichaela B Kirschner, Emily Pulford, Mir Alireza Hoda, et al.
Pageof 9